IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 3273 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE Here 
    Next article
    Previous article
    Table of Contents

 RESOURCE Links
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed14280    
    Printed226    
    Emailed15    
    PDF Downloaded607    
    Comments [Add]    
    Cited by others 6    

Recommend this journal

 

 VIEW POINT
Year : 2009  |  Volume : 75  |  Issue : 3  |  Page : 229--235

The conundrum of parapsoriasis versus patch stage of mycosis fungoides


Sundaram Medical Foundation, Dr. Rangarajan Memorial Hospital, Chennai, Tamilnadu, India

Correspondence Address:
K N Sarveswari
Sundaram Medical Foundation, Dr. Rangarajan Memorial Hospital, Shanthi Colony - IV Avenue, Anna Nagar, Chennai - 600 040, Tamilnadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0378-6323.51239

Rights and Permissions

Terminological confusion with benign dermatosis, such as parapsoriasis en plaques, makes it difficult to diagnose mycosis fungoides in the early patch stage. Early diagnosis of mycosis fungoides (MF) is important for deciding on type of therapy, prognosis and for further follow-up. However, until recently, there has been no consensus on criteria that would help in diagnosing the disease early. Some believe that large plaque parapsoriasis (LPP) should be classified with early patch stage of MF and should be treated aggressively. However, there is no firm clinical or laboratory criteria to predict which LPP will progress to MF and we can only discuss about statistical probability. Moreover, long-term outcome analysis of even patch stage of MF is similar to that of control population. We therefore believe that LPP should be considered as a separate entity at least to prevent the patient from being given a frightening diagnosis. We also feel that patients need not be treated with aggressive therapy for LPP and will need only a close follow-up. This article emphasizes the criteria for diagnosing early MF and has highlighted the importance of considering LPP as a distinct benign entity.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow